Full text

Turn on search term navigation

© The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Innovative identification technologies for hematopoietic stem cells (HSCs) have expanded the scope of stem cell biology. Clinically, the functional quality of HSCs critically influences the safety and therapeutic efficacy of stem cell therapies. However, most analytical techniques capture only a single snapshot, disregarding the temporal context. A comprehensive understanding of the temporal heterogeneity of HSCs necessitates live-cell, real-time and non-invasive analysis. Here, we developed a prediction system for HSC diversity by integrating single-HSC ex vivo expansion technology with quantitative phase imaging (QPI)-driven machine learning. By analyzing the cellular kinetics of individual HSCs, we discovered previously undetectable diversity that snapshot analysis cannot resolve. The QPI-driven algorithm quantitatively evaluates stemness at the single-cell level and leverages temporal information to significantly improve prediction accuracy. This platform advances the field from snapshot-based identification of HSCs to dynamic, time-resolved prediction of their functional quality based on past cellular kinetics.

This study introduces a label-free imaging and machine learning platform that predicts hematopoietic stem cell function based on their dynamic behaviors, offering new insights into stem cell diversity and potential clinical applications.

Details

Title
Quantitative phase imaging with temporal kinetics predicts hematopoietic stem cell diversity
Author
Yogo, Takao 1   VIAFID ORCID Logo  ; Iwamoto, Yuichiro 2   VIAFID ORCID Logo  ; Becker, Hans Jiro 1   VIAFID ORCID Logo  ; Kimura, Takaharu 1   VIAFID ORCID Logo  ; Ishida, Reiko 1 ; Sugiyama-Finnis, Ayano 1 ; Yokomizo, Tomomasa 3 ; Suda, Toshio 4   VIAFID ORCID Logo  ; Ota, Sadao 2 ; Yamazaki, Satoshi 5   VIAFID ORCID Logo 

 The University of Tokyo, Division of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 The University of Tokyo, Research Center for Advanced Science and Technology, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2169 1048) 
 Tokyo Women’s Medical University, Department of Microscopic and Developmental Anatomy, Tokyo, Japan (GRID:grid.410818.4) (ISNI:0000 0001 0720 6587) 
 Kumamoto University, International Research Center for Medical Sciences, Tokyo, Japan (GRID:grid.274841.c) (ISNI:0000 0001 0660 6749); Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Stem Cell Biology Institute of Hematology, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 The University of Tokyo, Division of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Division of Cell Engineering, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Tsukuba University, Laboratory for Stem Cell Therapy, Faculty of Medicine, Ibaraki, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728) 
Pages
6496
Publication year
2025
Publication date
2025
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3230015589
Copyright
© The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.